tiprankstipranks
Advertisement
Advertisement
Novo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors
PremiumCompany AnnouncementsNovo Nordisk’s New Diabetes Bet: What the UBT251 Trial Could Mean for NVO Investors
5d ago
Novo Nordisk Ramps Up Share Buybacks Under DKK 15 Billion Programme
Premium
Company Announcements
Novo Nordisk Ramps Up Share Buybacks Under DKK 15 Billion Programme
6d ago
Novo Nordisk announces new data from phase 3 FRONTIER4 study of denecimig
Premium
The Fly
Novo Nordisk announces new data from phase 3 FRONTIER4 study of denecimig
7d ago
Novo Nordisk Withdraws CagriSema Device Study, Nudging Investor Focus Back to Core Obesity Assets
PremiumCompany AnnouncementsNovo Nordisk Withdraws CagriSema Device Study, Nudging Investor Focus Back to Core Obesity Assets
10d ago
Hims & Hers (HIMS) Stock Still Has Upside, but Risks Persist
Premium
Market News
Hims & Hers (HIMS) Stock Still Has Upside, but Risks Persist
10d ago
Novo Nordisk announces updated semaglutide label in Singapore
Premium
The Fly
Novo Nordisk announces updated semaglutide label in Singapore
11d ago
Microsoft Parachuting 6,000 AI Engineers into Global Clients as Part of New $2.5B AI Subsidiary
PremiumMarket NewsMicrosoft Parachuting 6,000 AI Engineers into Global Clients as Part of New $2.5B AI Subsidiary
17d ago
Moderately bullish activity in Novo Nordisk with shares up 1.51%
Premium
The Fly
Moderately bullish activity in Novo Nordisk with shares up 1.51%
18d ago
Novo Nordisk Stock (NVO) Rises as Medicare Starts Covering Obesity Drugs
Premium
Market News
Novo Nordisk Stock (NVO) Rises as Medicare Starts Covering Obesity Drugs
18d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100